The Effect of Methylphenidate on Attention in Acquired Brain Injury as Recorded by Useful Field of View

Patients: A series of 16 patients diagnosed with traumatic brain injury (n = 12) and subarachnoid hemorrhage (n = 4) were followed before and after taking methylphenidate, as a part of treatment for clinically identified atten-tional deficit. Results: The introduction of methylphenidate correlated with an improvement in processing speed loss, divided attention loss, and selective attention loss on the UFOV test. Methylphenidate use was further correlated with improvement on FIM Cognition and FIM Activity of Daily Living subscales. Conclusions: Methylphenidate use, in an inpatient population of patients with ABI, resulted in a significant improve-Objectives: To assess the ability of the Useful Field of View (UFOV) test to measure change in attention of patients with acquired brain injury (ABI) when given methylphenidate in an inpatient rehabilitation unit. Design: This study reviewed data from consecutive patients who were given methylphenidate while being monitored for visual processing speed, divided attention, and selective attention with the UFOV test. Changes in UFOV scores were also compared with changes in Functional Impairment Measures (FIM). ment in attention and divided attention, which can be measured by the UFOV. This change in attentional ability seems to correlate with improvement in the cognitive and the Activity of Daily Living subscales of the FIM. INTRODUCTION In the United States approximately 70,000 to 90,000 individuals incur acquired brain injury (ABI) every year, resulting in long-term substantial loss of functioning. 1 One of the intransigent and pervasive sequels of ABI is hypoatten-tion. This is often seen as a serious barrier to the management, rehabilitation, and vocational adjustment of patients with ABI. 2 Impaired attentional functioning is likely to simulate or amplify other cognitive and emotional impairments , as well as intensify difficulties with activities of daily living. 3 The long-term outcome of patients with ABI is thought to be limited as much by hypoattention as by physical or other cognitive impairments.